Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) Short Interest Up 220.0% in October

Harrow Health, Inc. 11.875% Senior Notes due 2027 (NASDAQ:HROWM) was the target of a large increase in short interest during the month of October. As of October 15th, there was short interest totalling 1,600 shares, an increase of 220.0% from the September 30th total of 500 shares. Based on an average daily volume of 4,500 shares, the short-interest ratio is presently 0.4 days.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Price Performance

Shares of HROWM stock traded down $0.07 during trading hours on Friday, reaching $26.17. The company had a trading volume of 4,897 shares, compared to its average volume of 4,125. Harrow Health, Inc. 11.875% Senior Notes due 2027 has a 12-month low of $22.71 and a 12-month high of $27.72. The stock has a fifty day moving average of $26.54 and a 200-day moving average of $26.39.

Harrow Health, Inc. 11.875% Senior Notes due 2027 Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, October 31st. Investors of record on Tuesday, October 15th will be given a $0.7422 dividend. The ex-dividend date of this dividend is Tuesday, October 15th. This represents a $2.97 annualized dividend and a yield of 11.34%.

About Harrow Health, Inc. 11.875% Senior Notes due 2027

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.